Brief: Altamira Therapeutics Reports Full Year 2024 Results
30/04/2025 13:23
April 30 (Reuters) - Altamira Therapeutics Ltd CYTOF.PK: ALTAMIRA THERAPEUTICS PROVIDES BUSINESS UPDATE, REPORTS FULL YEAR 2024 FINANCIAL RESULTS ALTAMIRA THERAPEUTICS LTD - PLANS PARTIAL SPIN-OFF OF RNA DELIVERY BUSINESS Source text: ID:nGNX2R4M2N Further company coverage: CYTOF.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering